Codexis to Participate in Jefferies Global Healthcare Conference

REDWOOD CITY, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will attend the Jefferies Global Healthcare Conference, being held June 5-6, 2024, in New York, New York.

Management will participate in a fireside chat on Wednesday, June 5, 2024, at 11:30 am ET. A live webcast of the event will be available here and in the Investor Relations section of the Company’s website, http://ir.codexis.com. A replay will be archived for 90 days following the event.

About Codexis

Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® technology platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis™ manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com.

For More Information

Investor ContactCarrie McKim(336) 608-9706[email protected]

Media ContactLauren Musto(650) 421-8205[email protected]

You May Also Be Interested In

• Computer Modelling Group Announces Annual General Meeting Voting Results
• Laura Ruplėnaitė-Beresnevičienė Announces Book on Law and the Decalogue as Her Faith-Inspired Mobile Photography Reaches an International Audience
• $9.9 Million Revenue for First Half of 2026, a 25% Increase Over Same Period in 2025 for Emerging AI and Robotics Developer Baird Medical Investment Holdings (Nasdaq: BDMD)